Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice

Kidney International

Volumn 69, Issue 1, 2006, Pages 73-80

  Chow, F Y ^a,b   Nikolic Paterson, D J ^a,b   Ozols, E ^a   Atkins, R C ^a,b   Rollin, B J ^c   Tesch, G H ^a,b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Diabetic nephropathy; Inducible nitric oxide synthase; Macrophage; Monocyte chemoattractant protein 1; Renal injury; Streptozotocin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CREATININE; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; MONOCYTE CHEMOTACTIC PROTEIN 1; SIALOADHESIN; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE MARKER; ENZYME ACTIVATION; GLOMERULUS; GLYCATION; HISTOPATHOLOGY; HYPERGLYCEMIA; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY TUBULE; KNOCKOUT MOUSE; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; STREPTOZOCIN DIABETES;

ANIMALS; CHEMOKINE CCL2; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; KIDNEY; MACROPHAGE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; STREPTOZOCIN;

EID: 30944456936     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000014     Document Type: Article

References (35)

1. Svensson M, Sundkvist G, Arnqvist HJ et al. Diabetes Incidence Study in Sweden (DISS): signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 2003; 26: 2903-2909.
2. Bohle A, Wehrmann M, Bogenschutz O et al. The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. Pathol Res Pract 1991; 187: 251-259.
3. Furuta T, Saito T, Ootaka T et al. The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 1993; 21: 480-485.
4. Sassy-Prigent C, Heudes D, Mandet C et al. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 2000; 49: 466-475.
5. Chow F, Ozols E, Nikolic-Paterson DJ et al. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 2004; 65: 116-128.
6. Nikolic-Paterson DJ, Lan HY, Atkins RC. Macrophages in immune renal injury. In: Neilson EG, Couser WG (eds). Immunologic Renal Diseases. Lippincott-Raven Publishers: Philadelphia; 1997, pp 575-592.
7. Ikezumi Y, Hurst LA, Masaki T et al. Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial proliferation. Kidney Int 2003; 63: 83-95.
8. Utimura R, Fujihara CK, Mattar AL et al. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int 2003; 63: 209-216.
9. Anders HJ, Vielhauer V, Schlondorff D. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 2003; 63: 401-415.
10. Mezzano S, Aros C, Droguett A et al. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant 2004; 19: 2505-2512.
11. lpr mice. J Exp Med 1999; 190: 1813-1824.
12. Biswas SK, Sodhi A, Paul S. Regulation of nitric oxide production by murine peritoneal macrophages treated in vitro with chemokine monocyte chemoattractant protein 1. Nitric Oxide 2001; 5: 566-579.
13. Biswas SK, Sodhi A. In vitro activation of murine peritoneal macrophages by monocyte chemoattractant protein-1: upregulation of CD11b, production of proinflammatory cytokines, and the signal transduction pathway. J Interferon Cytokine Res 2002; 22: 527-538.
14. Kato S, Luyckx VA, Ots M et al. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats. Kidney Int 1999; 56: 1037-1048.
15. Morii T, Fujita H, Narita T et al. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J Diabetes Complications 2003; 17: 11-15.
16. Banba N, Nakamura T, Matsumura M et al. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 2000; 58: 684-690.
17. Amann B, Tinzmann R, Angelkort B. ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. Diabetes Care 2003; 26: 2421-2425.
18. Mezzano S, Droguett A, Burgos ME et al. Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int 2003; 86(Suppl): S64-S70.
19. Tesch GH, Schwarting A, Kinoshita K; et al. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 1999; 103: 73-80.
20. van den Berg TK, van Die I, de Lavalette CR et al. Regulation of sialoadhesin expression on rat macrophages. Induction by glucocorticoids and enhancement by IFN-beta, IFN-gamma, IL-4 and lipopolysaccharide. J Immunol 1996; 157: 3130-3138.
21. Pulliam L, Sun B, Rempel H. Invasive chronic inflammatory phenotype in subjects with high HIV-1 viral load. J Neuroimmunol 2004; 157: 93-98.
22. Brandonisio O, Panaro MA, Fumarola I et al. Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages. Clin Exp Med 2002; 2: 125-112.
23. Trachtman H, Futterweit S, Pine E et al. Chronic diabetic nephropathy: role of inducible nitric oxide synthase. Pediatr Nephrol 2002; 17: 20-29.
24. Soulis T, Cooper ME, Sastra S et al. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats. Diabetologia 1997; 40: 1141-1151.
25. Amore A, Cirina P, Conti G et al. Amadori-configurated albumin induces nitric oxide-dependent apoptosis of endothelial cells: a possible mechanism of diabetic vasculopathy. Nephrol Dial Transplant 2004; 19: 53-60.
26. Luther SA, Cyster JG. Chemokines as regulators of T cell differentiation. Nat Immunol 2001; 2: 102-107.
27. Le Meur Y, Tesch GH, Hill PA et al. Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway. J Leuk Biol 2002; 72: 530-537.
28. Chow FY, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transplant 2004; 19: 2987-2996.
29. Wu CH, Huang CM, Lin CH et al. Advanced glycation end-products induce NF-kappaB dependent iNOS expression in RAW 264*7 cells. Mol Cell Endocrinol 2002; 194: 9-17.
30. Bassi AM, Ledda S, Valentini S et al. Damaging effects of advanced glycation end-products in the murine macrophage cell line J774A.1. Toxicol In Vitro 2002; 16: 339-347.
31. Rashid G, Luzon AA, Korzets Z et al. The effects of advanced glycation end-products and aminoguanidine on TNF-α production by rat peritoneal macrophages. Perit Dial Int 2001; 21: 122-129.
32. Versey DA, Cheung CW, Cuttle L et al. Interleukin-1 beta stimulates human renal fibroblast proliferation and matrix production by means of a transforming growth factor-beta-dependent mechanism. J Lab Clin Med 2002; 140: 342-350.
33. Chow FY, Nikolic-Paterson DJ, Ozols E et al. Intracellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol 2005; 16: 1711-1722.
34. Lu B, Rutledge BJ, Gu L et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998; 187: 601-608.
35. Lan HY, Mu W, Nikolic-Paterson DJ, Atkins RC. A novel, simple, reliable, and sensitive method for multiple immunoenzyme labeling: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem 1995; 43: 97-102.